Detection of a Peripheral Blood T Cell Clone is an Independent Prognostic Marker in Mycosis Fungoides
about
Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementProteomic Approaches to Biomarker Discovery in Cutaneous T-Cell LymphomaMycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.Diverse cutaneous manifestations associated with a single disease.Management of the primary cutaneous lymphomas.Diagnosis, staging, and monitoring of cutaneous T-cell lymphoma.Treatment planning in cutaneous T-cell lymphoma.Syringotropic cutaneous T-cell lymphoma: an immunophenotypic and genotypic study of five cases.TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythrodermaStaging and management of cutaneous T-cell lymphoma.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Molecular detection of circulating Sezary cells in patients with mycosis fungoides: could it predict future development of secondary Sezary syndrome? A single-institution experience.Detection of circulating tumor cells using GeneScan analysis for antigen receptor gene rearrangements in canine lymphoma patients.BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement.Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T-cell and B-cell lymphoproliferative disorders.Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients.Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone.A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.Rare occurrence of CD30+ circulating cells in patients with cutaneous CD30+ anaplastic large cell lymphoma: a study of nine patients.Neoplasms
P2860
Q27024076-01421DD4-E109-4CFE-91D3-749B300D78B1Q28071331-C5EBA4B8-89EB-4A42-89C8-9712AC2AC801Q30252152-B256CDC2-0F08-468F-9A5B-5A695266DFE9Q34116799-C5F24C16-E35A-4F54-82CB-38762D75FC79Q35583232-D0CD7F76-469D-48C0-89BB-0F2E6D76A55FQ35612009-C33B4B21-1CEF-42DC-8931-D0C0088BE98CQ35612011-7FA16A03-9EBB-4BBC-A010-40DB23BEAD21Q35843841-B8BEA7AA-B570-4A9C-8EF2-5A9926552304Q36310531-68F0C402-D039-407B-AC16-B58D89A6F8F5Q36399825-B080688B-A217-4B71-99EA-BF8000F45E73Q36470196-DB63524E-D578-4F1F-8627-091F667069F2Q37379370-BED72CB9-83AC-4DEB-9431-079EC431B1C5Q37944565-A3990626-B602-4F7C-8659-98552B5DAEB6Q39691435-7975F05D-C926-4AA8-8BD0-BEEF3F176BB8Q41771773-49B7C31A-21A1-42EA-81A1-89F9CF3DF13EQ41943654-131F192C-3F9B-4617-A193-BAB2FC165EBAQ43734642-093070B0-2D35-445A-B087-026ABFAB5220Q47690374-232B9903-7D1A-4DEE-81C7-695904D27726Q48017352-89243138-B9B6-4DE0-BD44-474356D3A14AQ48017360-2748191D-C79C-4DC4-9295-E59A7275574EQ48034709-CEDAF0AC-8F6D-4B8C-AB21-C1F09BB0B304Q52876668-27DA85A6-1425-47DC-AD16-EC79DF714F8AQ53368714-1F057AC8-AB2F-4E15-9D95-CF3D81D62ABCQ53635286-9520BA91-F790-4E5E-B29F-55CA0F91B5AAQ54582099-981130B1-F2BD-4A4A-9DA5-ED073A2E6B54Q54789382-F8BEEC4A-2EA3-4D58-9DAF-2F466B625AE5Q56828372-77D7FF20-FEAA-44C0-98AD-B77ED418D010
P2860
Detection of a Peripheral Blood T Cell Clone is an Independent Prognostic Marker in Mycosis Fungoides
description
im Januar 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2000
@uk
name
Detection of a Peripheral Bloo ...... ic Marker in Mycosis Fungoides
@en
Detection of a Peripheral Bloo ...... ic Marker in Mycosis Fungoides
@nl
type
label
Detection of a Peripheral Bloo ...... ic Marker in Mycosis Fungoides
@en
Detection of a Peripheral Bloo ...... ic Marker in Mycosis Fungoides
@nl
prefLabel
Detection of a Peripheral Bloo ...... ic Marker in Mycosis Fungoides
@en
Detection of a Peripheral Bloo ...... ic Marker in Mycosis Fungoides
@nl
P2093
P1476
Detection of a Peripheral Bloo ...... ic Marker in Mycosis Fungoides
@en
P2093
Alison J. Woolford
Elisabeth A. Fraser-Andrews
Robin Russell-Jones
Sean J. Whittaker
P304
P356
10.1046/J.1523-1747.2000.00830.X
P407
P50
P577
2000-01-01T00:00:00Z
P6179
1039420579